{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:59:47Z","timestamp":1792011587016,"version":"4.4.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,11,12]],"date-time":"2013-11-12T00:00:00Z","timestamp":1384214400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s00417-013-2512-3","type":"journal-article","created":{"date-parts":[[2013,11,11]],"date-time":"2013-11-11T08:00:02Z","timestamp":1384156802000},"page":"873-879","source":"Crossref","is-referenced-by-count":30,"title":["Pars plana vitrectomy for treatment of advanced Coats\u2019 disease\u2014presentation of a modified surgical technique and long-term follow-up"],"prefix":"10.1007","volume":"252","author":[{"given":"Daniela","family":"Suesskind","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Altpeter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merle","family":"Schrader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl U.","family":"Bartz-Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Aisenbrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,12]]},"reference":[{"key":"2512_CR1","first-page":"440","volume":"17","author":"G Coats","year":"1908","unstructured":"Coats G (1908) Forms of retinal diseases with massive exudation. R Lond Ophthalmol Hosp Rep 17:440\u2013525","journal-title":"R Lond Ophthalmol Hosp Rep"},{"key":"2512_CR2","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0002-9394(00)00883-7","volume":"131","author":"JA Shields","year":"2001","unstructured":"Shields JA, Shields CL, Honovar SG, Demirci H (2001) Clinical variations and complications of Coats disease in 150 cases: the 2000 Sanford Gifford memorial lecture. Am J Ophthalmol 131:561\u2013571","journal-title":"Am J Ophthalmol"},{"key":"2512_CR3","first-page":"89","volume":"19","author":"SW Silodor","year":"1988","unstructured":"Silodor SW, Augsburger JJ, Shields JA, Tasman W (1988) Natural history and management of advanced Coats\u2019 disease. Ophthalmic Surg 19:89\u201393","journal-title":"Ophthalmic Surg"},{"key":"2512_CR4","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0002-9394(01)00896-0","volume":"131","author":"JA Shields","year":"2000","unstructured":"Shields JA, Shields CL, Honovar SG, Demirci H, Cater J (2000) Classification and management of Coats\u2019 disease: the 2000 Proctor Lecture. Am J Ophthalmol 131:572\u2013583","journal-title":"Am J Ophthalmol"},{"key":"2512_CR5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/00006982-200202000-00014","volume":"22","author":"JA Shields","year":"2001","unstructured":"Shields JA, Shields CL (2001) Review: Coats disease. The 2001 LuEsther T. Mertz lecture. Retina 22:80\u201391","journal-title":"Retina"},{"key":"2512_CR6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s003470170146","volume":"98","author":"L Krause","year":"2001","unstructured":"Krause L, Kreusel K-M, Jandeck C, Kellner U, Foerster MH (2001) Vitrektomie bei fortgeschrittenem Morbus Coats. Ophthalmologe 98:387\u2013390","journal-title":"Ophthalmologe"},{"key":"2512_CR7","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/sj.eye.6700019","volume":"16","author":"G Kranias","year":"2002","unstructured":"Kranias G, Krebs TP (2002) Advanced Coats\u2019 disease successfully managed with vitreo-retinal surgery. Eye 16:500\u2013501","journal-title":"Eye"},{"key":"2512_CR8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000323616","volume":"2","author":"G Muftuoglu","year":"2011","unstructured":"Muftuoglu G, Gulkilik G (2011) Pars plana vitrectomy in advanced Coats\u2019 disease. Case Rep Ophthalmol 2:15\u201322","journal-title":"Case Rep Ophthalmol"},{"key":"2512_CR9","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1097\/IAE.0b013e31816b3158","volume":"28","author":"S Mrejen","year":"2008","unstructured":"Mrejen S, Metge F, Denion E, Dureau P, Edelson C, Capuot G (2008) Management of retinal detachment in Coats' disease. Study of 15 cases. Retina 28:S26\u2013S32","journal-title":"Retina"},{"key":"2512_CR10","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF01268124","volume":"90","author":"MO Yoshizumi","year":"1995","unstructured":"Yoshizumi MO, Kreiger AE, Lewis H, Foxman B, Hakakha B (1995) Vitrectomy techniques in late-stage Coats'-like exudative retinal detachment. Doc Ophthalmol 90:387\u2013394","journal-title":"Doc Ophthalmol"},{"key":"2512_CR11","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1755-3768.2008.01253.x","volume":"87","author":"PK Sterigiou","year":"2009","unstructured":"Sterigiou PK, Symeonidis C, Dimitrakos SA (2009) Coats\u2019 disease: treatment with intravitreal bevacizumab and laser photocoagulation. Acta Ophthalmol (Copenh) 87:687\u2013688","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"2512_CR12","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1111\/j.1755-3768.2009.01514.x","volume":"88","author":"P Cackett","year":"2010","unstructured":"Cackett P, Wong D, Cheung CMG (2010) Combined intravitreal bevacizumab and argon laser treatment for Coats\u2019 disease. Acta Ophthalmol (Copenh) 88:e48\u2013e49","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"2512_CR13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4103\/0301-4738.58482","volume":"58","author":"Entezari","year":"2010","unstructured":"Entezari, Ramezani A, Safavizadeh L, Bassimia N (2010) Resolution of macular edema in Coats\u2019 disease with intravitreal bevacizumab. Indian J Ophthalmol 58:80\u201382","journal-title":"Indian J Ophthalmol"},{"key":"2512_CR14","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4103\/0301-4738.58480","volume":"58","author":"S Kaul","year":"2010","unstructured":"Kaul S, Uparkar M, Mody K, Walinjkar J, Kothari M, Natarajan S (2010) Intravitreal anti-vascular endothelial growth factor agents as an adjunct in the management of Coats\u2019 disease in children. Indian J Ophthalmol 58:76\u201378","journal-title":"Indian J Ophthalmol"},{"key":"2512_CR15","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s00417-011-1629-5","volume":"249","author":"MRR B\u00f6hm","year":"2011","unstructured":"B\u00f6hm MRR, Uhlig CE (2011) Use of intravitreal triamcinolone and bevacizumab in Coats\u2019 disease with central macular edema. Graefes Arch Clin Exp Ophthalmol 249:1099\u20131101","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2512_CR16","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00417-010-1563-y","volume":"249","author":"T Zhao","year":"2011","unstructured":"Zhao T, Wang K, Ma Y, Jiang Y-R (2011) Resolution of total retinal detachment in Coats\u2019 disease with intravitreal injection of bevacizumab. Graefes Arch Clin Exp Ophthalmol 249:1745\u20131746","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2512_CR17","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ophtha.2011.09.059","volume":"119","author":"NG Ghazi","year":"2012","unstructured":"Ghazi NG, Al Shamsi H, Larsson J, Abboud E (2012) Intravitreal triamcinolone in Coats\u2019 disease. Ophthalmology 119:648\u2013649","journal-title":"Ophthalmology"},{"key":"2512_CR18","author":"X-X Zheng","year":"2013","unstructured":"Zheng X-X, Jiang Y-R (2013) The effect of intravitreal bevacizumab injection as the initial treatment for Coats\u2019 disease. Graefes Arch Clin Exp Ophthalmol Jul 20 [Epub ahead of print]. doi: 10.1007\/s00417-013-2409-1","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2512_CR19","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/bjophthalmol-2012-302250","volume":"97","author":"R Ray","year":"2013","unstructured":"Ray R, Bara\u00f1ano DE, Hubbard GB (2013) Treatment of Coats\u2019 disease with intravitreal bevacizumab. Br J Ophthalmol 97:272\u2013277","journal-title":"Br J Ophthalmol"},{"key":"2512_CR20","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3928\/0191-3913-20010901-05","volume":"38","author":"JA Shields","year":"2001","unstructured":"Shields JA, Shields CL (2001) Differentiation of Coats\u2019 disease and retinoblastoma. J Pediatr Ophthalmol Strabismus 38:262\u2013266","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"2512_CR21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ophtha.2012.07.067","volume":"120","author":"CL Shields","year":"2013","unstructured":"Shields CL, Schoenberg E, Kocher K, Shukla SY, Kaliki S, Shields JA (2013) Lesions simulating retinoblastoma (pseudoretinoblastoma) in 604 cases. Results based on age at presentation. Ophthalmology 120:311\u2013316","journal-title":"Ophthalmology"},{"key":"2512_CR22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1350-9462(97)00007-4","volume":"17","author":"H Nagasaki","year":"1998","unstructured":"Nagasaki H, Shinagawa K, Mochizuki M (1998) Risk factors for proliferative vitreoretinopathy. Prog Retin Eye Res 17:77\u201398","journal-title":"Prog Retin Eye Res"},{"key":"2512_CR23","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00006982-198600630-00008","volume":"6","author":"AK Singh","year":"1986","unstructured":"Singh AK, Michels RG, Glaser BM (1986) Scleral indentation following cryotherapy and repeat cryotherapy enhance release of viable retinal epithelial cells. Retina 6:176\u2013178","journal-title":"Retina"},{"key":"2512_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3341\/kjo.1995.9.1.1","volume":"9","author":"JH Lee","year":"1995","unstructured":"Lee JH, Kim SJ, Chung H (1995) The effect of subtenon injection of methylprednisolone acetate on the breakdown of blood retinal barrier after cryotherapy. Korean J Ophthalmol 9:1\u20136","journal-title":"Korean J Ophthalmol"},{"key":"2512_CR25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3928\/0191-3913-19790701-12","volume":"16","author":"GP Theodossiadis","year":"1974","unstructured":"Theodossiadis GP (1974) Some clinical, fluorescein-angiographic, and therapeutic aspects of Coats\u2019 disease. J Pediatr Ophthalmol Strabismus 16:257\u2013262","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"2512_CR26","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ajo.2010.10.024","volume":"151","author":"MJ Shapiro","year":"2011","unstructured":"Shapiro MJ, Show CC, Karth PA, Kiernan DF, Blair MP (2011) Effects of green diode laser in the treatment of pediatric Coats' disease. Am J Ophthalmol 151:725\u2013731","journal-title":"Am J Ophthalmol"},{"key":"2512_CR27","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1097\/IAE.0b013e318163cd7c","volume":"28","author":"AC Schefler","year":"2008","unstructured":"Schefler AC, Berrocal A, Murray T (2008) Advanced Coats\u2019 disease. Management with repetitive aggressive laser ablation therapy. Retina 28:S38\u2013S41","journal-title":"Retina"},{"key":"2512_CR28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000027253","volume":"212","author":"H Kirath","year":"1998","unstructured":"Kirath H, Eldem B (1998) Management of moderate to advanced Coats\u2019 disease. Ophthalmologica 212:19\u201322","journal-title":"Ophthalmologica"},{"key":"2512_CR29","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1038\/eye.2010.127","volume":"24","author":"A Mulvihill","year":"2010","unstructured":"Mulvihill A, Morris B (2010) A population-based study of Coats' disease in the United Kingdom II: investigation, treatment, and outcomes. Eye 24:1802\u20131807","journal-title":"Eye"},{"key":"2512_CR30","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/bjophthalmol-2011-300141","volume":"96","author":"A Ramasubramanian","year":"2012","unstructured":"Ramasubramanian A, Shields CL (2012) Bevacizumab for Coats\u2019 disease with exudative retinal detachment and risk of vitreoretinal traction. Br J Ophthalmol 96:356\u2013359","journal-title":"Br J Ophthalmol"},{"key":"2512_CR31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/bjo.84.1.37","volume":"84","author":"DH Char","year":"2000","unstructured":"Char DH (2000) Coats\u2019 syndrome: long-term follow-up. Br J Ophthalmol 84:37\u201339","journal-title":"Br J Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-013-2512-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-013-2512-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-013-2512-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T00:25:27Z","timestamp":1647044727000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-013-2512-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,12]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["2512"],"URL":"https:\/\/doi.org\/10.1007\/s00417-013-2512-3","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,12]]}}}